Trials / Completed
CompletedNCT04085133
Prevalence and Burden of Bronchiectasis in Tuberculous Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- —
Summary
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree
Detailed description
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree. The prevalence of bronchiectasis is age-related and occurs in every age group and in the pre-antibiotic era . it most often began in childhood. Recent evidence shows that bronchiectasis disproportionately affects women and older individuals and will be contributing to increase in healthcare burden.\[3\] International data show an increase in the prevalence of bronchiectasis over recent years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Gene Xpert Chest x ray and MSCT chest | Sputum sample for T.B will be done using gene expert device and chest xray and high resolution ct to evaluate bronchectasis |
Timeline
- Start date
- 2019-09-26
- Primary completion
- 2020-01-01
- Completion
- 2020-04-01
- First posted
- 2019-09-11
- Last updated
- 2023-02-17
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04085133. Inclusion in this directory is not an endorsement.